Table 2 Incidence of adverse events
System organ class/preferred term | Subjects, no. | |
|---|---|---|
Stage C (n = 9) | Stage D (n = 11) | |
Cardiac disorders | 0 | 0 |
Congestive heart failure  | 0 | 0 |
Gastrointestinal disorders | 0 | 0 |
GERD  | 0 | 0 |
Peripheral edema  | 0 | 0 |
Immune system disorders | 0 | 0 |
Seasonal allergies  | 0 | 0 |
Infections and infestations | 0 | 0 |
Bronchitis  | 0 | 0 |
Nasopharyngitis  | 0 | 0 |
Pneumonia  | 0 | 0 |
Skin infection  | 0 | 0 |
Upper respiratory tract infection  | 0 | 0 |
Urinary tract infection  | 0 | 0 |
Blood calcium increase  | 0 | 0 |
Transient C-reactive protein increase  | 3 | 2 |
Metabolic and nutritional disorders | 0 | 0 |
Hyperglycemia  | 0 | 0 |
Type 2 diabetes mellitus  | 0 | 0 |
Transient hypertension | 5 | 4 |